Expression of ACTB in testis cancer - The Human Protein Atlas

TESTICULAR GERM CELL TUMOR (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

ACTB is not prognostic in Testicular Germ Cell Tumor (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 5186.6

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

5-year survival highⁱ N/A

5-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

7578.7

Number of samples

133

Samples

Sample	Description	pTPM
TCGA-ZM-AA05-01A	36 years, male, white, stage:Stage IIC, alive, 1126 days	40074.5
TCGA-YU-AA4L-01A	27 years, male, black or african american, stage:Stage IIIC, alive, 1573 days	27833.6
TCGA-2G-AAGF-01A	28 years, male, white, stage:Stage IS, alive, 2734 days	20470.5
TCGA-2G-AAGT-01A	30 years, male, white, stage:Stage IS, alive, 4406 days	19869.1
TCGA-2G-AAL7-01A	32 years, male, white, stage:Stage IS, alive, 3991 days	19506.1
TCGA-2G-AAKD-01A	18 years, male, white, stage:Stage III, alive, 6340 days	19364.0
TCGA-VF-A8AB-01A	31 years, male, black or african american, stage:Stage IA, alive, 760 days	18029.3
TCGA-2G-AAHC-01A	33 years, male, white, stage:Stage IS, alive, 5539 days	16191.4
TCGA-2G-AAFE-01A	37 years, male, white, stage:Stage IIA, alive, 4702 days	15470.6
TCGA-XY-A8S2-01A	67 years, male, white, stage:Stage I, alive, 672 days	14296.0
TCGA-2G-AAGN-01A	41 years, male, white, stage:Stage IIIB, alive, 3656 days	14255.2
TCGA-YU-AA61-01A	29 years, male, white, stage:Stage IS, alive, 864 days	13749.5
TCGA-2G-AAKL-01A	26 years, male, white, stage:Stage II, alive, 7023 days	13707.5
TCGA-2G-AAGW-01A	38 years, male, white, stage:Stage IS, alive, 4899 days	13116.1
TCGA-2G-AAFL-01A	35 years, male, white, stage:Stage IB, alive, 750 days	13064.4
TCGA-2G-AAKM-01A	14 years, male, white, stage:Stage II, dead, 6972 days	12730.1
TCGA-2G-AAFV-01A	31 years, male, white, stage:Stage IS, alive, 1389 days	12472.4
TCGA-2G-AAGS-01A	39 years, male, white, stage:Stage IIIB, alive, 4816 days	12464.0
TCGA-ZM-AA0N-01A	44 years, male, white, stage:Stage IB, alive, 634 days	12404.5
TCGA-ZM-AA0D-01A	34 years, male, white, stage:Stage IA, alive, 848 days	12025.5
TCGA-SN-A84Y-01A	18 years, male, white, stage:Stage IS, alive, 524 days	11937.2
TCGA-X3-A8G4-01A	33 years, male, white, stage:Stage IS, alive, 856 days	11438.4
TCGA-2G-AAGA-01A	38 years, male, white, stage:Stage IIA, alive, 2439 days	11032.9
TCGA-XE-AAOF-01A	50 years, male, asian, stage:Stage IA, alive, 1268 days	10787.7
TCGA-XE-AANJ-01A	39 years, male, white, stage:Stage IS, alive, 2007 days	10746.8
TCGA-2G-AAGV-01A	23 years, male, white, stage:'--, alive, 4527 days	10572.6
TCGA-W4-A7U3-01A	26 years, male, white, stage:'--, alive, 149 days	10327.5
TCGA-XE-A9SE-01A	35 years, male, white, stage:Stage IA, alive, 708 days	10187.8
TCGA-2G-AAG8-01A	21 years, male, white, stage:Stage IB, alive, 2289 days	9943.0
TCGA-VF-A8AE-01A	39 years, male, white, stage:Stage IA, alive, 727 days	9574.0
TCGA-2G-AAFM-01A	31 years, male, white, stage:Stage IIA, alive, 503 days	9288.6
TCGA-ZM-AA0F-01A	35 years, male, white, stage:Stage IA, alive, 681 days	9257.3
TCGA-ZM-AA0B-01A	32 years, male, white, stage:Stage IA, alive, 838 days	9030.0
TCGA-2G-AALP-01A	43 years, male, white, stage:Stage IIIB, alive, 2645 days	8955.3
TCGA-SB-A76C-01A	38 years, male, white, stage:'--, alive, 42 days	8822.3
TCGA-XE-AAOJ-01A	24 years, male, white, stage:Stage IS, alive, 1550 days	8641.6
TCGA-4K-AAAL-01A	31 years, male, white, stage:Stage IS, alive, 483 days	8605.2
TCGA-2G-AAKG-01A	22 years, male, white, stage:Stage I, alive, 6598 days	8356.3
TCGA-ZM-AA0E-01A	39 years, male, white, stage:Stage IA, alive, 811 days	8297.7
TCGA-2G-AAEX-01A	38 years, male, white, stage:Stage IS, alive, 1259 days	8063.7
TCGA-2G-AAFY-01A	24 years, male, white, stage:Stage IIA, alive, 1099 days	8005.5
TCGA-2G-AAGE-01A	21 years, male, white, stage:Stage IS, alive, 2478 days	7654.3
TCGA-YU-A90S-01A	26 years, male, white, stage:Stage IA, alive, 971 days	7590.4
TCGA-2G-AAFN-01A	26 years, male, white, stage:Stage IIIB, alive, 773 days	7578.3
TCGA-YU-A94I-01A	66 years, male, stage:Stage IA, alive, 536 days	7460.1
TCGA-WZ-A7V3-01A	20 years, male, white, stage:Stage I, alive, 753 days	7384.5
TCGA-2G-AAG7-01A	33 years, male, white, stage:Stage IS, alive, 2475 days	7302.1
TCGA-VF-A8A9-01A	31 years, male, white, stage:Stage IA, alive, 1119 days	7293.7
TCGA-4K-AA1G-01A	34 years, male, white, stage:Stage IS, alive, 436 days	7256.7
TCGA-2G-AAHN-01A	32 years, male, white, stage:Stage I, alive, 6445 days	7234.8
TCGA-2G-AAG0-01A	23 years, male, white, stage:Stage IS, alive, 1529 days	7040.0
TCGA-XE-AAO6-01A	47 years, male, white, stage:Stage IA, alive, 240 days	6961.3
TCGA-2G-AAFO-01A	33 years, male, white, stage:Stage IIA, alive, 685 days	6948.6
TCGA-ZM-AA0H-01A	50 years, male, white, stage:Stage IS, alive, 1736 days	6926.8
TCGA-4K-AA1H-01A	26 years, male, white, stage:Stage IA, alive, 518 days	6889.4
TCGA-VF-A8A8-01A	18 years, male, white, stage:Stage IA, alive, 1131 days	6883.4
TCGA-2G-AAGK-01A	20 years, male, white, stage:Stage IS, alive, 3621 days	6797.6
TCGA-2G-AAHL-01A	26 years, male, white, stage:Stage I, alive, 7081 days	6734.8
TCGA-S6-A8JX-01A	27 years, male, white, stage:Stage IB, alive, 552 days	6682.7
TCGA-2G-AAHT-01A	32 years, male, white, stage:Stage IS, alive, 542 days	6667.2
TCGA-XY-A9T9-01A	37 years, male, white, stage:Stage IS, alive, 281 days	6419.8
TCGA-XY-A89B-01A	35 years, male, white, stage:Stage IA, alive, 471 days	6392.2
TCGA-VF-A8AD-01A	36 years, male, white, stage:Stage IB, alive, 1006 days	6214.4
TCGA-VF-A8AC-01A	29 years, male, white, stage:Stage IA, alive, 1083 days	6200.3
TCGA-2G-AAGX-01A	22 years, male, white, stage:Stage IA, alive, 5514 days	6135.4
TCGA-2G-AAG6-01A	24 years, male, white, stage:Stage IS, alive, 2231 days	6016.3
TCGA-4K-AA1I-01A	26 years, male, white, stage:Stage IA, alive, 3 days	5870.2
TCGA-2G-AAGP-01A	33 years, male, white, stage:Stage IIA, alive, 4018 days	5852.8
TCGA-XE-AAOL-01A	38 years, male, black or african american, stage:Stage I, alive, 13 days	5838.4
TCGA-2G-AAGZ-01A	27 years, male, white, stage:Stage IIIA, alive, 5233 days	5830.6
TCGA-2G-AAHA-01A	48 years, male, white, stage:Stage IB, alive, 3349 days	5823.3
TCGA-W4-A7U4-01A	23 years, male, white, stage:'--, alive, 738 days	5693.0
TCGA-2G-AAH4-01A	34 years, male, white, stage:Stage II, alive, 6210 days	5544.2
TCGA-2G-AAGY-01A	28 years, male, white, stage:Stage IS, alive, 5329 days	5446.8
TCGA-2G-AAH2-01A	20 years, male, white, stage:Stage IS, alive, 6060 days	5407.5
TCGA-2G-AAGC-01A	28 years, male, white, stage:Stage IS, alive, 2585 days	5303.8
TCGA-XE-AANI-01A	37 years, male, white, stage:Stage IS, alive, 1041 days	5296.8
TCGA-YU-A90P-01A	25 years, male, white, stage:Stage IA, alive, 2069 days	5296.8
TCGA-2G-AAFG-01A	30 years, male, white, stage:Stage IS, alive, 6183 days	5295.8
TCGA-SN-A6IS-01A	26 years, male, white, stage:Stage IS, alive, 496 days	5289.8
TCGA-2G-AAH3-01A	20 years, male, white, stage:Stage I, alive, 1822 days	5186.6
TCGA-YU-A90Y-01A	23 years, male, black or african american, stage:Stage IIIC, dead, 17 days	5053.9
TCGA-2G-AAG5-01A	36 years, male, white, stage:Stage IS, alive, 2299 days	5015.9
TCGA-XE-AAO4-01A	40 years, male, white, stage:Stage IA, alive, 367 days	5011.2
TCGA-2G-AAKH-01A	19 years, male, white, stage:Stage II, alive, 6862 days	5010.0
TCGA-WZ-A8D5-01A	38 years, male, white, stage:'--, alive, 774 days	4996.4
TCGA-2G-AAFZ-01A	32 years, male, white, stage:Stage III, alive, 1353 days	4947.1
TCGA-XE-AAOB-01A	27 years, male, white, stage:Stage IS, dead, 513 days	4889.5
TCGA-VF-A8AA-01A	51 years, male, white, stage:Stage I, alive, 1146 days	4852.0
TCGA-2G-AAGG-01A	20 years, male, white, stage:Stage IIIC, alive, 2611 days	4847.5
TCGA-2G-AAGI-01A	33 years, male, white, stage:Stage IS, alive, 3137 days	4839.4
TCGA-2G-AAFI-01A	41 years, male, white, stage:Stage IB, alive, 675 days	4789.8
TCGA-2G-AAL5-01A	31 years, male, white, stage:Stage I, alive, 7437 days	4744.4
TCGA-XE-AAOC-01A	31 years, male, white, stage:Stage IA, alive, 270 days	4684.5
TCGA-XE-A8H5-01A	29 years, male, stage:Stage IS, alive, 1217 days	4593.2
TCGA-XE-A8H1-01A	24 years, male, white, stage:Stage IS, alive, 209 days	4588.6
TCGA-2G-AAGJ-01A	28 years, male, black or african american, stage:Stage IA, alive, 2938 days	4479.8
TCGA-SN-A84X-01A	21 years, male, white, stage:Stage IS, alive, 312 days	4478.6
TCGA-2G-AAHP-01A	31 years, male, white, stage:Stage IS, alive, 5667 days	4445.9
TCGA-ZM-AA06-01A	45 years, male, white, stage:Stage IB, alive, 1498 days	4423.9
TCGA-2G-AAEW-01A	31 years, male, white, stage:Stage IS, dead, 618 days	4370.0
TCGA-YU-A912-01A	34 years, male, black or african american, stage:Stage IIIC, alive, 866 days	4254.0
TCGA-2G-AAFJ-01A	23 years, male, asian, stage:'--, alive, 792 days	4171.0
TCGA-YU-A94D-01A	28 years, male, stage:Stage IIIB, alive, 2167 days	4138.2
TCGA-XE-AAO3-01A	33 years, male, asian, stage:Stage I, alive, 2857 days	4105.2
TCGA-2G-AAH0-01A	30 years, male, white, stage:Stage IS, alive, 5477 days	4094.9
TCGA-SN-A84W-01A	30 years, male, white, stage:Stage IS, alive, 293 days	4092.3
TCGA-2G-AAF4-01A	30 years, male, white, stage:Stage I, alive, 2315 days	4064.4
TCGA-2G-AAGM-01A	51 years, male, white, stage:Stage IS, alive, 3891 days	4059.5
TCGA-XE-A8H4-01A	23 years, male, white, stage:Stage IA, alive, 559 days	4054.3
TCGA-YU-A90W-01A	45 years, male, white, stage:Stage IA, alive, 1113 days	3992.3
TCGA-WZ-A7V4-01A	28 years, male, white, stage:Stage I, alive, 894 days	3981.4
TCGA-2G-AAH8-01A	45 years, male, white, stage:Stage IIIC, alive, 2248 days	3941.4
TCGA-2G-AAF1-01A	28 years, male, asian, stage:Stage IS, alive, 1403 days	3919.2
TCGA-2G-AAG9-01A	25 years, male, white, stage:Stage IIIB, alive, 2234 days	3817.8
TCGA-2X-A9D6-01A	42 years, male, white, stage:Stage I, alive, 607 days	3812.7
TCGA-2G-AAGO-01A	41 years, male, white, stage:Stage IS, alive, 4026 days	3807.3
TCGA-XE-AAOD-01A	39 years, male, white, stage:Stage IB, alive, 2058 days	3710.2
TCGA-S6-A8JW-01A	37 years, male, white, stage:Stage IS, alive, 698 days	3684.0
TCGA-2G-AAG3-01A	53 years, male, white, stage:Stage IS, alive, 1593 days	3534.5
TCGA-2G-AAFH-01A	38 years, male, white, stage:Stage IIB, alive, 1375 days	3493.9
TCGA-2G-AAF6-01A	28 years, male, white, stage:Stage IS, alive, 3491 days	3405.9
TCGA-SB-A6J6-01A	22 years, male, white, stage:Stage IA, alive, 413 days	3394.5
TCGA-W4-A7U2-01A	26 years, male, white, stage:'--, alive, 1263 days	3368.6
TCGA-XE-AANR-01A	23 years, male, white, stage:Stage I, alive, 14 days	3253.2
TCGA-2X-A9D5-01A	49 years, male, white, stage:Stage I, alive, 435 days	3219.3
TCGA-XE-AANV-01A	52 years, male, stage:Stage IB, alive, 1701 days	3195.0
TCGA-S6-A8JY-01A	27 years, male, white, stage:Stage IS, alive, 278 days	3158.1
TCGA-2G-AAHG-01A	25 years, male, white, stage:Stage I, alive, 1819 days	3073.7
TCGA-WZ-A7V5-01A	27 years, male, white, stage:Stage I, alive, 1061 days	2724.7
TCGA-2G-AAF8-01A	33 years, male, white, stage:Stage IA, alive, 3911 days	2452.7
TCGA-YU-A90Q-01A	21 years, male, stage:Stage IB, alive, 1964 days	2174.0
TCGA-SO-A8JP-01A	29 years, male, white, stage:Stage I, alive, 540 days	2159.8
Show allShow less

TESTIS CANCER - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA041264	Antibody HPA041271	Antibody CAB002621
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Carcinoma, Embryonal, NOS
Seminoma, NOS
Seminoma, NOS Carcinoma, Embryonal, NOS